As a result of advocacy by The Royal Pharmaceutical Society and the Pharmaceutical Society of Australia, the International Pharmaceutical Federation, the global body representing pharmacy and pharmaceutical sciences, is now leading action on the role of pharmacists in addressing the issue of antimicrobial resistance.
FIP will develop a briefing document on the role of pharmacists in AMR, ready for FIP’s Annual congress in Düsseldorf starting on 29 September 2015.
The document will aim to prompt action on the issue of antibiotics and AMR, and to serve as a foundation for future work within FIP on this topic, including a revision of the FIP statement on AMR.
The topic of AMR and responsible use of antimicrobials will also be discussed at a stakeholder roundtable held prior to the 2016 FIP Congress in Buenos Aires.
Both PSA and RPS say they believe that AMR continues to be a very serious public health risk and needs to be treated as a high priority within national and international strategies – governmental, health and professional.
The PSA and RPS are encouraging strong AMR stewardship amongst FIP membership, assistance in sharing current evidence, and raising the profile of pharmacists’ role in antimicrobial stewardship.
Ashok Soni, President of RPS, welcomed the response by FIP to the PSA-RPS initiative.
“We worked with PSA in leading this initiative because pharmacists can play a leading role in addressing this serious issue,” Soni says.
“We have an important responsibility to ensure appropriate use of antimicrobials.”
National President of the PSA, Grant Kardachi, says that AMR is one of the most critical health issues affecting population across the globe.
Kardachi says that we not only need much greater investment in identifying new antibiotics, but we also need a much stronger response by those at the front line of care.
“We look forward to working further with RPS and FIP to progress this initiative and make a real difference in the battle against antimicrobial resistance,” he says.